PublizoomBIOCON BIOLOGICS BELGIUM
Company number 0801.406.278
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 2
- Amount won alone
- €3,078,901 excl. VAT
- Period
- 13 May 2025 – 29 September 2025
Its main clients
- MercurHosp ASBL · 1 contract
- VITAZ vzw · 1 contract
Where and what
Supplies · 2
East Flanders · 1
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 4 August 2027 re-tender around February 2027 |
Fourniture de Bevacizumab
MercurHosp ASBL |
BIOCON BIOLOGICS BELGIUM 4 bids received |
€398,901 |
| 24 April 2029 re-tender around October 2028 |
Bevacizumab
VITAZ vzw framework agreement |
BIOCON BIOLOGICS BELGIUM 4 bids received |
€2,680,000 |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 29/09/2025 | Fourniture de Bevacizumab | MercurHosp ASBL | €398,901 |
| 13/05/2025 | Bevacizumab | VITAZ vzw | €2,680,000 |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.